EcoDrugPlus

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSELUG00000019340
Gene Symbol: GRM4
1 Cross references
200 Possible Orthologues:

Glutamate Receptor 1

Ensembl ID : ENSELUG00000020875
Gene Symbol: LOC105025957
3 Cross references
250 Possible Orthologues:

Glutamate Receptor 1

Ensembl ID : ENSELUG00000006017
Gene Symbol: LOC105007042
3 Cross references
252 Possible Orthologues:

Glutamate Receptor 2

Ensembl ID : ENSELUG00000005296
Gene Symbol: LOC105007598
3 Cross references
239 Possible Orthologues:

Glutamate Receptor 3

Ensembl ID : ENSELUG00000007731
Gene Symbol: LOC105025980
3 Cross references
254 Possible Orthologues:

Glutamate Receptor 4

Ensembl ID : ENSELUG00000018146
Gene Symbol: LOC105011059
3 Cross references
252 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSELUG00000016714
Gene Symbol: LOC105024190
3 Cross references
204 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSELUG00000009298
Gene Symbol: LOC105027821
3 Cross references
152 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2d

Ensembl ID : ENSELUG00000015612
Gene Symbol: LOC105019083
2 Cross references
213 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 2b

Ensembl ID : ENSELUG00000020476
Gene Symbol: GRIA2B
1 Cross references
257 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSELUG00000003050
Gene Symbol: GRIN2BB
1 Cross references
256 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSELUG00000020841
Gene Symbol: GRM5A
1 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).